Boston Scientific Corp. | Ownership
Companies that own Boston Scientific Corp.
Fidelity Management & Research Co.
151,138,898
10.93%
13,456,496
0.54%
06/30/2018
Capital Research & Management Co. (World Investors)
107,755,822
7.79%
350,718
0.54%
06/30/2018
The Vanguard Group, Inc.
98,021,112
7.09%
1,693,292
0.11%
06/30/2018
Wellington Management Co. LLP
67,027,103
4.84%
-1,454,446
0.45%
06/30/2018
BlackRock Fund Advisors
62,733,323
4.54%
-2,655,766
0.11%
06/30/2018
SSgA Funds Management, Inc.
54,113,833
3.91%
2,505,004
0.14%
06/30/2018
PRIMECAP Management Co.
44,807,141
3.24%
87,100
1.08%
06/30/2018
Henderson Global Investors Ltd.
41,739,459
3.02%
273,848
0.65%
06/30/2018
The Bollard Group LLC
33,511,504
2.42%
-143,537
50.46%
06/30/2018
JPMorgan Investment Management, Inc.
29,539,590
2.14%
2,748,918
0.34%
06/30/2018
| Address |
300 Boston Scientific Way
Marlborough Massachusetts 01752
United States
|
|
Employees
|
- |
| Website |
http://www.bostonscientific.com |
| Updated |
07/08/2019 |
| Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Cardiovascular, Rhythm Management, and MedSurg. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease, and other cardiovascular disorders including structural heart conditions. |
